These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 1578361

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL, Doyle JJ, Israels ED, Winter JS, Cheang MS, Walker RD, Bishop AJ.
    Lancet; 1985 Jun 08; 1(8441):1293-4. PubMed ID: 2860491
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Antagonism of antidiuretic hormone in domestic pigs (Sus scrofa).
    Monaghan ML, Divers T, Huffman WF, Kinter LB.
    Gen Pharmacol; 1993 Jul 08; 24(4):1013-20. PubMed ID: 8224729
    [Abstract] [Full Text] [Related]

  • 45. Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats.
    Liu HW, Wang YX, Crofton JT, Funyu T, Share L.
    Brain Res; 1996 May 06; 719(1-2):14-22. PubMed ID: 8782858
    [Abstract] [Full Text] [Related]

  • 46. Effect of cyclo-oxygenase blockade on the renal actions of vasopressin and SK&F 105494 in the rhesus monkey.
    Brooks DP, Caldwell NC, Koster PF, Albrightson-Winslow CR, Kinter LB.
    Br J Pharmacol; 1990 Apr 06; 99(4):750-2. PubMed ID: 2113824
    [Abstract] [Full Text] [Related]

  • 47. Cardiovascular and renin responses to desmopressin in humans: role of prostacyclin and beta-adrenergic systems.
    Hasunuma K, Yamada K, Tamura Y, Yoshida S.
    Am J Physiol; 1991 Apr 06; 260(4 Pt 2):H1031-6. PubMed ID: 1849368
    [Abstract] [Full Text] [Related]

  • 48. DDAVP-induced increases in coagulation factor VIII and von Willebrand factor in the plasma of conscious dogs.
    Johnson GS, Kraus KH, Turrentine MA, Dean PW.
    J Vet Pharmacol Ther; 1986 Dec 06; 9(4):370-5. PubMed ID: 3100823
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Improved hemophilia A carrier detection by DDAVP stimulation of factor VIII.
    Kobrinsky NL, Watson CM, Cheang MS, Bishop AJ.
    J Pediatr; 1984 May 06; 104(5):718-24. PubMed ID: 6425482
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The release of factor VIII and tissue plasminogen activator can not be blocked by specific antagonists to vasopressin.
    Vilhardt H, Barth T.
    J Recept Res; 1991 May 06; 11(1-4):239-45. PubMed ID: 1909360
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. DDAVP, cryoprecipitate, and highly 'purified' factor VIII concentrate in uremia.
    Juhl A.
    Nephron; 1986 May 06; 43(4):305-6. PubMed ID: 3090461
    [No Abstract] [Full Text] [Related]

  • 57. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
    Vincente V, Corrales J, Miralles J, Alberca I.
    Thromb Res; 1987 Mar 01; 45(5):695-7. PubMed ID: 3109066
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H, Barth T, Melin P, Aurell CJ.
    Eur J Pharmacol; 1993 Mar 02; 232(2-3):223-6. PubMed ID: 8467859
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.